Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 08, 2023
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 21, 2023
Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Journal: Science (New York, N.Y.)
Published: November 03, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026